Admitted local publications that cite HBsAg glycan isomer predicts on-treatment HBsAg decline in low-HBsAg chronic hepatitis B on nucleos(t)ide therapy.
No admitted local citation edges point to this work yet.
Cited by — HBsAg glycan isomer predicts on-treatment HBsAg decline in low-HBsAg chronic hepatitis B on nucleos(t)ide therapy | ResearchHub - ResearchHub
